Search clinical trials for: emerging infectious disease

Total 381430 results

ANRS, Emerging Infectious Diseases
Institut Pasteur

Unknown

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt (HepNile)

Chronic Hepatitis C

Egypt
ANRS, Emerging Infectious Diseases

Completed

First-Line Treatment for HIV-2 (FIT-2)

HIV-2 Infection

Côte D'Ivoire, Burkina Faso, Senegal, Togo
ANRS, Emerging Infectious Diseases
Aix Marseille Université; Fondation de France; Université du Québec a Montréal; Centre Population et Développement (CEPED), Paris, France and other collaborators

Unknown

ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali

HIV/AIDS | HIV Seropositivity | Empowerment | Disclosure

Mali
ANRS, Emerging Infectious Diseases

Completed

Lipopeptide Immunisation With GTU-multiHIV Trial

HIV-1 Infection

France
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; Fondation... and other collaborators

Unknown

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia (Cam-C)

Hepatitis C | Testing
ANRS, Emerging Infectious Diseases

Completed

IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection (INTESTIPAX)

HIV Reservoirs

France
French National Agency for Research on AIDS and...

Completed

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (EP46 NOVAA)

HIV Infection | Yellow Fever

France
ANRS, Emerging Infectious Diseases

Unknown

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children) (CLEAC)

HIV Infection

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Ministry of Health, Brazil

Completed

Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (REFLATE TB2)

Tuberculosis | HIV-1 Infection

France, Vietnam, Brazil, Côte D'Ivoire, Mozambique
Mexican Emerging Infectious Diseases Clinical Research...
National Institute of Allergy and Infectious Diseases (NIAID); Secretaria de...

Terminated

Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico (CNSARI)

Severe Acute Respiratory Infection (SARI)

Mexico
ANRS, Emerging Infectious Diseases

Completed

Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity ("ImmunoCo27")

HIV Infection
University Hospital, Bordeaux
ANRS, Emerging Infectious Diseases; Sidaction; Centre National de la Recherche...

Completed

Inflammasome Activation Via Circulating Metabolites (InflammoVIH)

Human Immunodeficiency Virus

France
Quan Dong Nguyen
Mallinckrodt

Unknown

ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) (ACTHAR)

Uveitis

United States
ANRS, Emerging Infectious Diseases
National Institute on Drug Abuse (NIDA)

Completed

Feasibility of Interventions on People Who Inject Drugs in Vietnam (DRIVE-IN)

HIV | Substance Abuse | Hepatitis Virus

Vietnam
National Institute of Allergy and Infectious Diseases...
Mexican Emerging Infectious Diseases Clinical Research Network

Completed

Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness (NTZ-SARI)

Severe Acute Respiratory Illness

Mexico
ANRS, Emerging Infectious Diseases
Hopital Paul Brousse

Withdrawn

Methylphenidate for Cocaine Dependence (ANRS STIMAGO)

Substance-Related Disorders

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Gilead Sciences

Completed

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients (VIH-2)

HIV-2 Infection

France
Institut de Médecine et d'Epidémiologie Appliquée...
ANRS, Emerging Infectious Diseases; Sidaction

Unknown

French HIV-HBV Cohort (COVViB)

End Stage Liver Disease | Liver Cirrhosis | Hepatitis B | HIV

France
ANRS, Emerging Infectious Diseases
St George's, University of London; Yaounde Central Hospital

Unknown

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS (PreCASA)

Cryptococcal Meningitis

Cameroon
Michael Hoelscher
German Federal Ministry of Education and Research; ANRS, Emerging Infectious... and other collaborators

Completed

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen (FATI-01)

HIV-1 Infection

Côte D'Ivoire, Tanzania
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; ANRS, Emerging Infectious Diseases; Institut...

Completed

Impact of the Fecal Flora Transplantation on Crohn's Disease (IMPACT-Crohn)

Crohn's Disease

France
ANRS, Emerging Infectious Diseases
IMEA Leon M'Ba Foundation; Unit 1136 INSERM, Faculty of medecine, University...

Unknown

Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients (QUATUOR)

HIV Infections

France
ANRS, Emerging Infectious Diseases
Bicetre Hospital; Pitié-Salpêtrière Hospital

Unknown

ANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint) (OncoVIHAC)

HIV Infected Patients With Cancer Treated by ICPi

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC

Completed

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study (HAND55-70)

HIV-1 Infection

France
ANRS, Emerging Infectious Diseases

Completed

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa (TAC)

HIV Infection | Hepatitis C

Cameroon, Côte D'Ivoire, Senegal
ANRS, Emerging Infectious Diseases
University Hospital, Grenoble; Hopital Antoine Beclere; Dr Yassine Taoufik Dr... and other collaborators

Completed

Cohort of HIV Associated Lymphomas (ANRS CO16)

HIV Infection

France
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza (IRC002)

Influenza A | Influenza B

United States
ANRS, Emerging Infectious Diseases
ViiV Healthcare

Completed

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

HIV-1 Infection

France
ANRS, Emerging Infectious Diseases

Completed

Evaluation of Raltegravir During the Third Trimester of Pregnancy (ANRS 160 RalFE)

HIV-1 Infection | PREGNANCY

France
ANRS, Emerging Infectious Diseases
Janssen Pharmaceuticals

Completed

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa (MOBIDIP)

HIV Infection

Cameroon, Burkina Faso, Senegal
ANRS, Emerging Infectious Diseases
Institut Pasteur

Withdrawn

Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C (ViZIR)

Chronic Hepatitis C

Egypt
ANRS, Emerging Infectious Diseases

Unknown

Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies (EDIRAPHIS)

HIV

France, Suriname
ANRS, Emerging Infectious Diseases

Unknown

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection (RIFAVIRENZ)

HIV | Tuberculosis

Uganda
ANRS, Emerging Infectious Diseases

Completed

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

HIV | Viral Hepatitis C

France
ANRS, Emerging Infectious Diseases

Completed

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Hepatitis C
ANRS, Emerging Infectious Diseases

Terminated

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

HIV Infection | HIV Seronegativity

France
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaborators

Completed

Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France (PARCOURS)

HIV Infection | Chronic Hepatitis B
ANRS, Emerging Infectious Diseases

Completed

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men (IPERGAY)

HIV Infection

France, Canada
ANRS, Emerging Infectious Diseases

Completed

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment (COPANA)

HIV Infection

France
French National Agency for Research on AIDS and...

Completed

Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients (ANRS 2H)

HIV Infections | Influenza

France
ANRS, Emerging Infectious Diseases
Ain Shams University; Institut Pasteur; Conservatoire national des Arts et Métiers

Unknown

Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C (IMMHoTHep)

Exposure to Hepatitis C Virus

Egypt
ANRS, Emerging Infectious Diseases
Gilead Sciences; Janssen Pharmaceutica

Completed

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé) (2LADY)

HIV Infections | HIV

Burkina Faso, Cameroon, Senegal
ANRS, Emerging Infectious Diseases

Unknown

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa (THILAO)

HIV Infection

Burkina Faso, Côte D'Ivoire, Mali, Senegal
French National Agency for Research on AIDS and...

Terminated

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance (PEGLIST C)

Insulin Resistance | Chronic Hepatitis C

France
ANRS, Emerging Infectious Diseases

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients (DARULIGHT)

HIV INFECTION

France
ANRS, Emerging Infectious Diseases

Completed

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin (CUPIC)

Chronic Hepatitis C

France
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

Hepatitis C Virus Genotype 4 Infection

France
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC

Completed

Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation

HCV Infection | Liver Cirrhosis, Experimental

France
ANRS, Emerging Infectious Diseases

Completed

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

HIV Infections

Cameroon

Search clinical trials for: emerging infectious disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations